Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Jazz Pharmaceuticals
Jazz Pharmaceuticals
FDA grants 'Priority Review' status to Jazz Pharmaceuticals' Xywav
Seeking Alpha
Mon, 04/12/21 - 11:20 pm
Jazz Pharmaceuticals
Jazz, in the hunt for new FDA nod, schools doctors on rare excessive sleepiness disorder
Fierce Pharma
Sat, 03/27/21 - 12:06 pm
Jazz Pharmaceuticals
FDA
idiopathic hypersomnia
Xywav
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Motley Fool
Wed, 03/17/21 - 10:39 am
stimulus
pharma stocks
Eli Lilly
Merck
Jazz Pharmaceuticals
AbbVie
Jazz CEO Bruce Cozadd campaigned for 6 months to buy GW Pharma. A 90% premium sealed the deal — along with $17.6M in ‘retention’ incentives
Endpoints
Sun, 03/7/21 - 01:33 pm
Jazz Pharmaceuticals
Pharma CEOs
Justin Glover
GW Pharma
M&A
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
Fierce Pharma
Thu, 01/14/21 - 10:37 pm
Jazz Pharmaceuticals
JPMHC 2021
Jazz launches new wave of marketing for Sunosi with TV ad and 50 new sales reps
Fierce Pharma
Fri, 01/8/21 - 09:36 am
Jazz Pharmaceuticals
Sunosi
obstructive sleep apnea
television ads
Jazz's $1B SCLC drug fails combo trial, quashing hopes of quick full approval
Endpoints
Thu, 12/3/20 - 10:52 am
Jazz Pharmaceuticals
lurbinectedin
small cell lung cancer
clinical trials
Jazz inks Redx pact to secure 2 targeted cancer therapies
Fierce Biotech
Wed, 09/9/20 - 10:34 am
Jazz Pharmaceuticals
Redx
cancer
targeted therapies
What's Behind Jazz Pharmaceuticals' Q2 Revenue and Earnings Beats
Motley Fool
Wed, 08/5/20 - 09:45 am
Jazz Pharmaceuticals
earnings
Jazz Pharmaceuticals gets FDA OK for cataplexy drug as it prepares to replace old cash cow
Endpoints
Wed, 07/22/20 - 10:42 am
Jazz Pharmaceuticals
Xywav
narcolepsy
cataplexy
FDA
Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod
Fierce Pharma
Mon, 06/22/20 - 08:37 pm
Jazz Pharmaceuticals
solid tumors
cancer
Zepzelca
drug launches
Why Jazz Pharmaceuticals Sang Off-Key in Q1
Motley Fool
Wed, 05/6/20 - 12:03 pm
Jazz Pharmaceuticals
earnings
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Yahoo/Simply Wall St
Thu, 02/27/20 - 10:26 am
Jazz Pharmaceuticals
earnings
Jazz targets US launch of SCLC drug after FDA grants fast review
Pharmaforum
Mon, 02/17/20 - 10:21 am
PharmaMar
Jazz Pharmaceuticals
FDA
small cell lung cancer
lurbinectedin
priority review
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Fri, 02/14/20 - 10:35 am
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
Jazz Pharma Files for FDA Approval of a New Narcolepsy Drug
Motley Fool
Wed, 01/22/20 - 11:06 pm
Jazz Pharmaceuticals
narcolepsy
JZP-258
FDA
Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More
Yahoo/Zacks.com
Mon, 11/4/19 - 07:33 pm
Allergan
Regeneron
Mylan
Catalent
Jazz Pharmaceuticals
Jazz Pharma Hits the Mark with Another Narcolepsy Treatment
BioSpace
Thu, 09/26/19 - 10:49 am
Jazz Pharmaceuticals
narcolepsy
JZP-258
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Sat, 09/21/19 - 12:28 pm
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »